marketcaparena
Search

    SYK

    STRYKER CORP

    Company overview

    Market capitalization
    $105.60B
    Employees
    56,000
    Latest publication
    2026-09-29
    About STRYKER CORP

    Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue6,589,000,000USD6,020,000,000USD7,171,000,000USD6,057,000,000USD6,022,000,000USD5,866,000,000USD6,436,000,000USD5,494,000,000USD
    Cost Of Revenue2,091,000,000USD2,210,000,000USD2,494,000,000USD2,205,000,000USD2,272,000,000USD2,186,000,000USD2,447,000,000USD2,101,000,000USD
    Gross Profit4,498,000,000USD3,810,000,000USD4,677,000,000USD3,852,000,000USD3,750,000,000USD3,680,000,000USD3,989,000,000USD3,393,000,000USD
    Research Development434,000,000USD413,000,000USD401,000,000USD410,000,000USD396,000,000USD393,000,000USD342,000,000USD364,000,000USD
    Selling General Administrative2,229,000,000USD2,281,000,000USD2,135,000,000USD2,045,000,000USD1,993,000,000USD2,300,000,000USD2,102,000,000USD1,896,000,000USD
    Other Operating Expenses175,000,000USD———————
    Total Operating Expenses2,839,000,000USD2,874,000,000USD2,716,000,000USD2,717,000,000USD2,389,000,000USD2,501,000,000USD2,326,000,000USD2,185,000,000USD
    Operating Income1,659,000,000USD936,000,000USD1,961,000,000USD1,135,000,000USD1,361,000,000USD1,179,000,000USD1,663,000,000USD1,208,000,000USD
    Total Other Income Expense Net-95,000,000USD-86,000,000USD-256,000,000USD-106,000,000USD-345,000,000USD-415,000,000USD-1,135,000,000USD-165,000,000USD
    Interest Expense141,000,000USD148,000,000USD381,000,000USD157,000,000USD159,000,000USD137,000,000USD——
    Income Before Tax1,564,000,000USD850,000,000USD1,705,000,000USD1,029,000,000USD1,016,000,000USD764,000,000USD528,000,000USD1,043,000,000USD
    Income Tax Expense288,000,000USD105,000,000USD856,000,000USD170,000,000USD132,000,000USD110,000,000USD-18,000,000USD209,000,000USD
    Net Income1,276,000,000USD745,000,000USD849,000,000USD859,000,000USD884,000,000USD654,000,000USD546,000,000USD834,000,000USD
    Unclassified Operating Expenses——180,000,000USD262,000,000USD—-192,000,000USD-118,000,000USD-75,000,000USD
    Interest Income——576,000,000USD28,000,000USD24,000,000USD38,000,000USD47,000,000USD30,000,000USD
    Tax Provision——856,000,000USD170,000,000USD132,000,000USD110,000,000USD-18,000,000USD209,000,000USD
    Net Income From Continuing Ops——849,000,000USD859,000,000USD884,000,000USD654,000,000USD546,000,000USD834,000,000USD
    Ebit——1,714,000,000USD1,029,000,000USD1,175,000,000USD764,000,000USD528,000,000USD1,043,000,000USD
    Ebitda——2,030,000,000USD1,363,000,000USD1,471,000,000USD1,036,000,000USD792,000,000USD1,311,000,000USD
    Depreciation And Amortization——316,000,000USD334,000,000USD296,000,000USD272,000,000USD264,000,000USD268,000,000USD
    Reconciled Depreciation——316,000,000USD309,000,000USD296,000,000USD272,000,000USD264,000,000USD268,000,000USD
    Net Income Applicable To Common Shares——849,000,000USD859,000,000USD884,000,000USD654,000,000USD546,000,000USD834,000,000USD
    Net Interest Income—————-137,000,000USD——
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue25,116,000,000USD22,595,000,000USD20,498,000,000USD18,449,000,000USD17,108,000,000USD14,351,000,000USD14,884,000,000USD13,601,000,000USD
    Cost Of Revenue9,051,000,000USD8,615,000,000USD8,004,000,000USD7,409,000,000USD6,399,000,000USD5,598,000,000USD5,502,000,000USD5,001,000,000USD
    Gross Profit16,065,000,000USD13,980,000,000USD12,494,000,000USD11,040,000,000USD10,709,000,000USD8,753,000,000USD9,382,000,000USD8,600,000,000USD
    Research Development1,582,000,000USD1,414,000,000USD1,293,000,000USD1,230,000,000USD1,133,000,000USD905,000,000USD971,000,000USD862,000,000USD
    Selling General Administrative8,221,000,000USD7,685,000,000USD7,129,000,000USD6,035,000,000USD5,752,000,000USD5,361,000,000USD5,356,000,000USD5,099,000,000USD
    Unclassified Operating Expenses1,373,000,000USD-180,000,000USD-209,000,000USD——-541,000,000USD-333,000,000USD-465,000,000USD
    Total Operating Expenses11,176,000,000USD8,919,000,000USD8,213,000,000USD7,306,000,000USD6,946,000,000USD5,725,000,000USD5,994,000,000USD5,496,000,000USD
    Operating Income4,889,000,000USD5,061,000,000USD4,281,000,000USD3,734,000,000USD3,763,000,000USD3,028,000,000USD3,388,000,000USD3,104,000,000USD
    Interest Income486,000,000USD257,000,000USD281,000,000USD243,000,000USD269,000,000USD213,000,000USD125,000,000USD139,000,000USD
    Interest Expense607,000,000USD396,000,000USD356,000,000USD337,000,000USD337,000,000USD315,000,000USD287,000,000USD264,000,000USD
    Net Interest Income-607,000,000USD-409,000,000USD-363,000,000USD—————
    Income Before Tax4,514,000,000USD3,492,000,000USD3,673,000,000USD2,683,000,000USD2,281,000,000USD1,954,000,000USD2,562,000,000USD2,356,000,000USD
    Income Tax Expense1,268,000,000USD499,000,000USD508,000,000USD325,000,000USD287,000,000USD355,000,000USD479,000,000USD-1,197,000,000USD
    Tax Provision1,268,000,000USD499,000,000USD508,000,000USD325,000,000USD287,000,000USD355,000,000USD479,000,000USD-1,197,000,000USD
    Net Income3,246,000,000USD2,993,000,000USD3,165,000,000USD2,358,000,000USD1,994,000,000USD1,599,000,000USD2,083,000,000USD3,553,000,000USD
    Net Income From Continuing Ops3,246,000,000USD2,993,000,000USD3,165,000,000USD2,358,000,000USD1,994,000,000USD1,599,000,000USD2,083,000,000USD3,553,000,000USD
    Ebit5,121,000,000USD3,888,000,000USD4,029,000,000USD3,020,000,000USD2,618,000,000USD2,269,000,000USD2,849,000,000USD2,620,000,000USD
    Ebitda6,314,000,000USD4,938,000,000USD5,057,000,000USD4,018,000,000USD3,608,000,000USD3,081,000,000USD3,627,000,000USD3,343,000,000USD
    Depreciation And Amortization1,193,000,000USD1,050,000,000USD1,028,000,000USD998,000,000USD990,000,000USD812,000,000USD778,000,000USD723,000,000USD
    Reconciled Depreciation1,193,000,000USD1,050,000,000USD1,028,000,000USD998,000,000USD990,000,000USD812,000,000USD778,000,000USD723,000,000USD
    Total Other Income Expense Net-375,000,000USD-1,569,000,000USD-608,000,000USD-1,051,000,000USD-1,482,000,000USD-1,074,000,000USD-826,000,000USD-748,000,000USD
    Net Income Applicable To Common Shares3,246,000,000USD2,993,000,000USD3,165,000,000USD2,358,000,000USD1,994,000,000USD1,599,000,000USD2,083,000,000USD3,553,000,000USD
    Non Operating Income Net Other———-158,000,000USD-303,000,000USD-269,000,000USD-151,000,000USD-181,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets47,930,000,000USD46,291,000,000USD47,844,000,000USD47,057,000,000USD46,331,000,000USD46,006,000,000USD42,971,000,000USD43,833,000,000USD
    Cash And Equivalents3,391,000,000USD2,878,000,000USD4,011,000,000USD3,256,000,000USD2,375,000,000USD2,320,000,000USD3,652,000,000USD3,850,000,000USD
    Total Current Assets14,418,000,000USD13,338,000,000USD14,755,000,000USD13,711,000,000USD13,003,000,000USD13,022,000,000USD14,847,000,000USD14,673,000,000USD
    Other Non Current Assets3,234,000,000USD3,169,000,000USD——————
    Total Liabilities23,942,000,000USD23,312,000,000USD——————
    Total Current Liabilities6,684,000,000USD6,315,000,000USD7,794,000,000USD7,414,000,000USD7,288,000,000USD7,929,000,000USD7,616,000,000USD7,669,000,000USD
    Other Current Liabilities2,604,000,000USD2,526,000,000USD——————
    Other Non Current Liabilities2,660,000,000USD2,370,000,000USD——————
    Total Equity Including Noncontrolling Interest23,988,000,000USD22,979,000,000USD——————
    Long Term Debt14,192,000,000USD14,224,000,000USD14,859,000,000USD14,845,000,000USD14,829,000,000USD14,383,000,000USD12,188,000,000USD13,325,000,000USD
    Net Receivables3,743,000,000USD3,571,000,000USD4,039,000,000USD3,643,000,000USD3,918,000,000USD3,961,000,000USD3,987,000,000USD3,736,000,000USD
    Inventory5,521,000,000USD5,419,000,000USD5,310,000,000USD5,370,000,000USD5,289,000,000USD5,105,000,000USD4,774,000,000USD5,292,000,000USD
    Property Plant Equipment Net3,958,000,000USD4,416,000,000USD4,395,000,000USD3,734,000,000USD4,253,000,000USD4,106,000,000USD3,964,000,000USD3,945,000,000USD
    Goodwill19,584,000,000USD19,188,000,000USD——————
    Intangible Assets5,742,000,000USD5,516,000,000USD5,681,000,000USD5,845,000,000USD5,962,000,000USD6,132,000,000USD4,395,000,000USD4,940,000,000USD
    Accounts Payable1,663,000,000USD1,592,000,000USD1,799,000,000USD1,498,000,000USD1,442,000,000USD1,464,000,000USD1,679,000,000USD1,337,000,000USD
    Short Term Debt750,000,000USD499,000,000USD1,153,000,000USD1,911,000,000USD1,910,000,000USD2,559,000,000USD1,553,000,000USD2,308,000,000USD
    Retained Earnings21,815,000,000USD20,878,000,000USD20,472,000,000USD19,960,000,000USD19,423,000,000USD18,862,000,000USD18,528,000,000USD18,303,000,000USD
    Accumulated Other Comprehensive Income-576,000,000USD-583,000,000USD-687,000,000USD-766,000,000USD-762,000,000USD-409,000,000USD-293,000,000USD-545,000,000USD
    Other Current Assets——1,306,000,000USD1,355,000,000USD1,332,000,000USD1,547,000,000USD1,593,000,000USD961,000,000USD
    Total Liab——25,424,000,000USD25,272,000,000USD25,140,000,000USD25,076,000,000USD22,337,000,000USD23,684,000,000USD
    Total Stockholder Equity——22,420,000,000USD21,785,000,000USD21,191,000,000USD20,930,000,000USD20,634,000,000USD20,149,000,000USD
    Other Current Liab——4,440,000,000USD4,005,000,000USD3,541,000,000USD3,534,000,000USD4,035,000,000USD3,630,000,000USD
    Common Stock——38,000,000USD38,000,000USD38,000,000USD38,000,000USD38,000,000USD38,000,000USD
    Capital Stock——38,000,000USD38,000,000USD38,000,000USD38,000,000USD38,000,000USD38,000,000USD
    Good Will——19,291,000,000USD19,256,000,000USD19,183,000,000USD19,089,000,000USD15,855,000,000USD16,396,000,000USD
    Other Assets——4,241,000,000USD3,972,000,000USD4,481,000,000USD3,657,000,000USD3,910,000,000USD3,879,000,000USD
    Cash——4,011,000,000USD3,256,000,000USD2,375,000,000USD2,320,000,000USD3,652,000,000USD3,850,000,000USD
    Cash And Short Term Investments——4,100,000,000USD3,343,000,000USD2,464,000,000USD2,409,000,000USD4,493,000,000USD4,684,000,000USD
    Net Debt——12,349,000,000USD14,254,000,000USD14,753,000,000USD15,036,000,000USD10,468,000,000USD12,157,000,000USD
    Short Long Term Debt——1,000,000,000USD1,750,000,000USD1,751,000,000USD2,398,000,000USD1,409,000,000USD2,159,000,000USD
    Short Long Term Debt Total——16,360,000,000USD17,510,000,000USD17,128,000,000USD17,356,000,000USD14,120,000,000USD16,007,000,000USD
    Short Term Investments——89,000,000USD87,000,000USD89,000,000USD89,000,000USD841,000,000USD834,000,000USD
    Property Plant Equipment Gross——7,537,000,000USD7,405,000,000USD7,272,000,000USD6,910,000,000USD6,683,000,000USD6,889,000,000USD
    Common Stock Shares Outstanding——386,500,000shares386,700,000shares386,400,000shares386,400,000shares386,100,000shares385,600,000shares
    Non Current Assets Total——33,089,000,000USD33,346,000,000USD33,328,000,000USD32,984,000,000USD28,124,000,000USD29,160,000,000USD
    Non Current Liabilities Total——17,630,000,000USD17,858,000,000USD17,852,000,000USD17,147,000,000USD14,721,000,000USD16,015,000,000USD
    Non Current Liabilities Other——2,369,000,000USD2,613,000,000USD2,628,000,000USD2,392,000,000USD2,184,000,000USD2,322,000,000USD
    Non Currrent Assets Other——2,622,000,000USD3,093,000,000USD2,552,000,000USD2,238,000,000USD2,129,000,000USD2,316,000,000USD
    Net Working Capital——6,961,000,000USD6,297,000,000USD5,715,000,000USD5,093,000,000USD7,231,000,000USD7,004,000,000USD
    Unclassified Non Current Assets——-3,141,000,000USD-2,554,000,000USD-3,103,000,000USD-2,238,000,000USD-2,129,000,000USD-2,316,000,000USD
    Unclassified Current Liabilities——-598,000,000USD-1,750,000,000USD-1,356,000,000USD-2,026,000,000USD-1,060,000,000USD-1,765,000,000USD
    Unclassified Non Current Liabilities——402,000,000USD400,000,000USD395,000,000USD372,000,000USD349,000,000USD368,000,000USD
    Unclassified Equity——2,559,000,000USD2,515,000,000USD2,454,000,000USD2,401,000,000USD2,323,000,000USD2,315,000,000USD
    Current Deferred Revenue———————-1,337,000,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets47,844,000,000USD42,971,000,000USD39,912,000,000USD36,884,000,000USD34,631,000,000USD34,330,000,000USD30,167,000,000USD27,229,000,000USD
    Intangible Assets5,681,000,000USD4,395,000,000USD4,593,000,000USD4,885,000,000USD4,840,000,000USD5,554,000,000USD4,227,000,000USD4,163,000,000USD
    Other Current Assets1,306,000,000USD1,684,000,000USD857,000,000USD787,000,000USD662,000,000USD488,000,000USD760,000,000USD747,000,000USD
    Total Liab25,424,000,000USD22,337,000,000USD21,319,000,000USD20,268,000,000USD19,754,000,000USD21,246,000,000USD17,360,000,000USD15,499,000,000USD
    Total Stockholder Equity22,420,000,000USD20,634,000,000USD18,593,000,000USD16,616,000,000USD14,877,000,000USD13,084,000,000USD12,807,000,000USD11,730,000,000USD
    Other Current Liab4,842,000,000USD3,989,000,000USD3,776,000,000USD3,286,000,000USD3,413,000,000USD3,470,000,000USD2,866,000,000USD2,630,000,000USD
    Common Stock38,000,000USD38,000,000USD38,000,000USD38,000,000USD38,000,000USD38,000,000USD37,000,000USD37,000,000USD
    Capital Stock38,000,000USD38,000,000USD38,000,000USD38,000,000USD38,000,000USD38,000,000USD37,000,000USD37,000,000USD
    Retained Earnings20,472,000,000USD18,528,000,000USD16,771,000,000USD14,765,000,000USD13,480,000,000USD12,462,000,000USD11,748,000,000USD10,765,000,000USD
    Good Will19,291,000,000USD15,855,000,000USD15,243,000,000USD14,880,000,000USD12,918,000,000USD12,778,000,000USD9,069,000,000USD8,563,000,000USD
    Other Assets4,241,000,000USD3,910,000,000USD3,849,000,000USD3,874,000,000USD4,023,000,000USD3,539,000,000USD2,560,000,000USD2,479,000,000USD
    Cash4,011,000,000USD3,652,000,000USD2,971,000,000USD1,844,000,000USD2,944,000,000USD2,943,000,000USD4,337,000,000USD3,616,000,000USD
    Cash And Equivalents4,011,000,000USD3,652,000,000USD2,971,000,000USD1,844,000,000USD2,944,000,000USD2,943,000,000USD4,337,000,000USD3,616,000,000USD
    Cash And Short Term Investments4,100,000,000USD4,402,000,000USD3,053,000,000USD1,928,000,000USD3,019,000,000USD3,024,000,000USD4,425,000,000USD3,699,000,000USD
    Total Current Assets14,755,000,000USD14,847,000,000USD12,518,000,000USD10,275,000,000USD10,017,000,000USD9,707,000,000USD11,360,000,000USD9,733,000,000USD
    Total Current Liabilities7,794,000,000USD7,616,000,000USD7,921,000,000USD6,303,000,000USD4,549,000,000USD5,041,000,000USD4,400,000,000USD4,807,000,000USD
    Net Debt12,349,000,000USD9,945,000,000USD10,523,000,000USD11,682,000,000USD9,528,000,000USD10,287,000,000USD5,894,000,000USD4,870,000,000USD
    Short Term Debt1,153,000,000USD1,409,000,000USD2,237,000,000USD1,312,000,000USD7,000,000USD761,000,000USD859,000,000USD1,373,000,000USD
    Short Long Term Debt1,000,000,000USD1,409,000,000USD2,094,000,000USD1,191,000,000USD7,000,000USD761,000,000USD859,000,000USD1,373,000,000USD
    Short Long Term Debt Total16,360,000,000USD1,409,000,000USD13,494,000,000USD13,526,000,000USD12,479,000,000USD13,991,000,000USD11,090,000,000USD9,859,000,000USD
    Long Term Debt14,859,000,000USD12,188,000,000USD10,901,000,000USD11,857,000,000USD12,472,000,000USD13,230,000,000USD10,231,000,000USD8,486,000,000USD
    Short Term Investments89,000,000USD750,000,000USD82,000,000USD84,000,000USD75,000,000USD81,000,000USD88,000,000USD83,000,000USD
    Net Receivables4,039,000,000USD3,987,000,000USD3,765,000,000USD3,565,000,000USD3,022,000,000USD2,701,000,000USD2,893,000,000USD2,332,000,000USD
    Inventory5,310,000,000USD4,774,000,000USD4,843,000,000USD3,995,000,000USD3,314,000,000USD3,494,000,000USD3,282,000,000USD2,955,000,000USD
    Accounts Payable1,799,000,000USD1,679,000,000USD1,517,000,000USD1,413,000,000USD1,129,000,000USD810,000,000USD675,000,000USD646,000,000USD
    Property Plant Equipment Net4,395,000,000USD3,448,000,000USD3,709,000,000USD3,443,000,000USD2,833,000,000USD2,752,000,000USD2,567,000,000USD2,291,000,000USD
    Property Plant Equipment Gross7,537,000,000USD6,683,000,000USD6,344,000,000USD5,805,000,000USD5,498,000,000USD2,752,000,000USD2,567,000,000USD2,291,000,000USD
    Accumulated Other Comprehensive Income-687,000,000USD-293,000,000USD-416,000,000USD-221,000,000USD-531,000,000USD-1,157,000,000USD-606,000,000USD-631,000,000USD
    Common Stock Shares Outstanding382,200,000shares385,600,000shares383,700,000shares382,200,000shares382,300,000shares380,300,000shares379,900,000shares380,300,000shares
    Non Current Assets Total33,089,000,000USD28,124,000,000USD27,394,000,000USD26,609,000,000USD24,614,000,000USD24,623,000,000USD18,807,000,000USD17,496,000,000USD
    Non Current Liabilities Total17,630,000,000USD14,721,000,000USD13,398,000,000USD13,965,000,000USD15,205,000,000USD16,205,000,000USD12,960,000,000USD10,692,000,000USD
    Non Current Liabilities Other2,369,000,000USD2,184,000,000USD1,930,000,000USD1,467,000,000USD1,820,000,000USD2,975,000,000USD2,729,000,000USD2,206,000,000USD
    Non Currrent Assets Other2,622,000,000USD2,684,000,000USD2,177,000,000USD1,901,000,000USD2,197,000,000USD2,005,000,000USD1,369,000,000USD2,479,000,000USD
    Net Working Capital6,961,000,000USD7,231,000,000USD4,597,000,000USD3,972,000,000USD5,468,000,000USD4,666,000,000USD6,960,000,000USD4,926,000,000USD
    Unclassified Non Current Assets-3,141,000,000USD-2,168,000,000USD-2,177,000,000USD-2,374,000,000USD-2,197,000,000USD-2,005,000,000USD-985,000,000USD-2,479,000,000USD
    Unclassified Current Liabilities-1,000,000,000USD-870,000,000USD-3,254,000,000USD-899,000,000USD—-761,000,000USD-859,000,000USD-1,373,000,000USD
    Unclassified Non Current Liabilities402,000,000USD349,000,000USD567,000,000USD-1,110,000,000USD-1,820,000,000USD-2,975,000,000USD-2,428,000,000USD-2,206,000,000USD
    Unclassified Equity2,559,000,000USD2,323,000,000USD2,162,000,000USD1,996,000,000USD1,852,000,000USD1,703,000,000USD1,591,000,000USD1,522,000,000USD
    Current Deferred Revenue——1,551,000,000USD————158,000,000USD
    Other Liab———1,751,000,000USD2,733,000,000USD2,975,000,000USD2,428,000,000USD2,206,000,000USD
    Accumulated Depreciation———-2,835,000,000USD-2,665,000,000USD-2,430,000,000USD-2,147,000,000USD-1,986,000,000USD
    Net Tangible Assets———-3,149,000,000USD-2,881,000,000USD-5,248,000,000USD-489,000,000USD-996,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Net Income2,021,000,000USD
    Depreciation596,000,000USD
    Stock Based Compensation141,000,000USD
    Deferred Income Tax74,000,000USD
    Other Non Cash Items1,000,000USD
    Change To Account Receivables267,000,000USD
    Change To Inventory-240,000,000USD
    Change To Liabilities-741,000,000USD
    Change In Working Capital-991,000,000USD
    Operating Cash Flow1,842,000,000USD
    Capital Expenditures-368,000,000USD
    Net Investments4,000,000USD
    Other Investing Activities-1,000,000USD
    Unclassified Investing Cash Flow-459,000,000USD
    Investing Cash Flow-824,000,000USD
    Net Debt Issuance-750,000,000USD
    Net Common Stock Issuance-146,000,000USD
    Common Dividends Paid-674,000,000USD
    Other Financing Activities-35,000,000USD
    Financing Cash Flow-1,605,000,000USD
    Effect Of Forex Changes On Cash-33,000,000USD
    Change In Cash-620,000,000USD
    End Cash Flow3,391,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Depreciation397,000,000USD316,000,000USD334,000,000USD296,000,000USD272,000,000USD264,000,000USD268,000,000USD258,000,000USD
    Stock Based Compensation87,000,000USD48,000,000USD62,000,000USD49,000,000USD84,000,000USD45,000,000USD51,000,000USD46,000,000USD
    Deferred Income Tax-33,000,000USD———————
    Change To Account Receivables444,000,000USD-397,000,000USD267,000,000USD113,000,000USD144,000,000USD-388,000,000USD-36,000,000USD-155,000,000USD
    Change To Inventory-127,000,000USD76,000,000USD-147,000,000USD-133,000,000USD-93,000,000USD156,000,000USD-132,000,000USD-46,000,000USD
    Change To Liabilities-654,000,000USD———————
    Change In Working Capital359,000,000USD709,000,000USD870,000,000USD-351,000,000USD-892,000,000USD461,000,000USD280,000,000USD-529,000,000USD
    Operating Cash Flow581,000,000USD———————
    Capital Expenditures-166,000,000USD-268,000,000USD-187,000,000USD-183,000,000USD-123,000,000USD-266,000,000USD-170,000,000USD-152,000,000USD
    Net Investments2,000,000USD———————
    Other Investing Activities-23,000,000USD———————
    Unclassified Investing Cash Flow2,000,000USD-10,000,000USD148,000,000USD203,000,000USD143,000,000USD265,000,000USD158,000,000USD122,000,000USD
    Investing Cash Flow-185,000,000USD———————
    Net Debt Issuance-1,000,000,000USD———————
    Net Common Stock Issuance-139,000,000USD———————
    Common Dividends Paid-337,000,000USD———————
    Other Financing Activities-34,000,000USD———————
    Financing Cash Flow-1,510,000,000USD———————
    Effect Of Forex Changes On Cash-19,000,000USD———————
    Change In Cash-1,133,000,000USD755,000,000USD881,000,000USD55,000,000USD-1,332,000,000USD-198,000,000USD1,976,000,000USD-456,000,000USD
    End Cash Flow2,878,000,000USD———————
    Net Income—849,000,000USD859,000,000USD884,000,000USD654,000,000USD546,000,000USD834,000,000USD825,000,000USD
    Other Non Cash Items—20,000,000USD-600,000,000USD71,000,000USD118,000,000USD964,000,000USD31,000,000USD25,000,000USD
    Total Cash From Operating Activities—2,143,000,000USD1,540,000,000USD1,111,000,000USD250,000,000USD1,931,000,000USD1,474,000,000USD633,000,000USD
    Free Cash Flow—1,875,000,000USD1,353,000,000USD928,000,000USD127,000,000USD1,665,000,000USD1,304,000,000USD481,000,000USD
    Investments—-8,000,000USD-321,000,000USD-104,000,000USD-4,136,000,000USD-303,000,000USD-2,172,000,000USD-117,000,000USD
    Total Cashflows From Investing Activities—-305,000,000USD-321,000,000USD-104,000,000USD-4,136,000,000USD-303,000,000USD-2,172,000,000USD-117,000,000USD
    Net Borrowings—-751,000,000USD-1,000,000USD-648,000,000USD2,979,000,000USD-1,438,000,000USD2,978,000,000USD—
    Total Cash From Financing Activities—-1,093,000,000USD-339,000,000USD-989,000,000USD2,534,000,000USD-1,794,000,000USD2,653,000,000USD-966,000,000USD
    Dividends Paid—-321,000,000USD-322,000,000USD-321,000,000USD-320,000,000USD-305,000,000USD-305,000,000USD-305,000,000USD
    Begin Period Cash Flow—3,256,000,000USD2,375,000,000USD2,320,000,000USD3,652,000,000USD3,850,000,000USD1,874,000,000USD2,330,000,000USD
    End Period Cash Flow—4,011,000,000USD3,256,000,000USD2,375,000,000USD2,320,000,000USD3,652,000,000USD3,850,000,000USD1,874,000,000USD
    Other Cashflows From Investing Activities—-19,000,000USD39,000,000USD-20,000,000USD-20,000,000USD1,000,000USD12,000,000USD30,000,000USD
    Other Cashflows From Financing Activities—-21,000,000USD649,000,000USD-6,000,000USD-24,000,000USD-2,000,000USD-1,000,000USD-48,000,000USD
    Unclassified Operating Cash Flow—201,000,000USD—162,000,000USD14,000,000USD-349,000,000USD—8,000,000USD
    Sale Purchase Of Stock——-17,000,000USD-14,000,000USD-101,000,000USD-49,000,000USD-19,000,000USD-14,000,000USD
    Unclassified Financing Cash Flow——-648,000,000USD————-599,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income3,246,000,000USD2,993,000,000USD3,165,000,000USD2,358,000,000USD1,994,000,000USD1,599,000,000USD2,083,000,000USD3,553,000,000USD
    Depreciation1,193,000,000USD1,050,000,000USD1,028,000,000USD998,000,000USD990,000,000USD812,000,000USD778,000,000USD723,000,000USD
    Stock Based Compensation243,000,000USD229,000,000USD205,000,000USD168,000,000USD171,000,000USD142,000,000USD127,000,000USD119,000,000USD
    Other Non Cash Items343,000,000USD1,023,000,000USD19,000,000USD-226,000,000USD66,000,000USD-190,000,000USD-253,000,000USD1,463,000,000USD
    Change To Account Receivables127,000,000USD-321,000,000USD-175,000,000USD-579,000,000USD-377,000,000USD354,000,000USD-563,000,000USD-60,000,000USD
    Change To Inventory-297,000,000USD-206,000,000USD-797,000,000USD-762,000,000USD-189,000,000USD27,000,000USD-400,000,000USD-385,000,000USD
    Change In Working Capital-373,000,000USD-683,000,000USD-500,000,000USD-732,000,000USD279,000,000USD866,000,000USD-670,000,000USD-1,666,000,000USD
    Total Cash From Operating Activities5,044,000,000USD4,242,000,000USD3,711,000,000USD2,624,000,000USD3,263,000,000USD3,277,000,000USD2,191,000,000USD2,610,000,000USD
    Capital Expenditures-761,000,000USD-755,000,000USD-575,000,000USD-588,000,000USD-525,000,000USD-487,000,000USD-649,000,000USD-572,000,000USD
    Free Cash Flow4,283,000,000USD3,487,000,000USD3,136,000,000USD2,036,000,000USD2,738,000,000USD2,790,000,000USD1,542,000,000USD2,038,000,000USD
    Investments750,000,000USD-3,000,000,000USD-972,000,000USD-2,924,000,000USD-859,000,000USD7,000,000USD-5,000,000USD168,000,000USD
    Total Cashflows From Investing Activities-4,866,000,000USD-3,000,000,000USD-962,000,000USD-2,924,000,000USD-859,000,000USD-4,701,000,000USD-1,455,000,000USD-2,857,000,000USD
    Net Borrowings1,579,000,000USD940,000,000USD-277,000,000USD472,000,000USD-1,153,000,000USD989,000,000USD1,293,000,000USD2,456,000,000USD
    Total Cash From Financing Activities113,000,000USD-525,000,000USD-1,594,000,000USD-749,000,000USD-2,365,000,000USD-11,000,000USD3,000,000USD1,329,000,000USD
    Dividends Paid-1,284,000,000USD-1,219,000,000USD-1,139,000,000USD-1,051,000,000USD-950,000,000USD-863,000,000USD-778,000,000USD-703,000,000USD
    Change In Cash359,000,000USD681,000,000USD1,127,000,000USD-1,100,000,000USD1,000,000USD-1,394,000,000USD721,000,000USD1,074,000,000USD
    Begin Period Cash Flow3,652,000,000USD2,971,000,000USD1,844,000,000USD2,944,000,000USD2,943,000,000USD4,337,000,000USD3,616,000,000USD2,542,000,000USD
    End Period Cash Flow4,011,000,000USD3,652,000,000USD2,971,000,000USD1,844,000,000USD2,944,000,000USD2,943,000,000USD4,337,000,000USD3,616,000,000USD
    Other Cashflows From Investing Activities-60,000,000USD43,000,000USD1,000,000USD-2,336,000,000USD5,000,000USD-4,221,000,000USD-801,000,000USD-2,000,000USD
    Other Cashflows From Financing Activities-182,000,000USD-51,000,000USD-23,000,000USD955,000,000USD-264,000,000USD3,149,000,000USD-205,000,000USD-124,000,000USD
    Unclassified Operating Cash Flow392,000,000USD-370,000,000USD-206,000,000USD58,000,000USD-237,000,000USD48,000,000USD126,000,000USD-1,582,000,000USD
    Unclassified Investing Cash Flow-4,795,000,000USD712,000,000USD584,000,000USD2,924,000,000USD520,000,000USD——-2,451,000,000USD
    Sale Purchase Of Stock—-195,000,000USD-155,000,000USD-122,000,000USD-114,000,000USD-110,000,000USD-307,000,000USD-300,000,000USD
    Change To Liabilities———223,000,000USD325,000,000USD13,000,000USD-106,000,000USD159,000,000USD
    Cash And Cash Equivalents Changes———-1,049,000,000USD39,000,000USD-1,435,000,000USD721,000,000USD1,074,000,000USD
    Unclassified Financing Cash Flow———-1,003,000,000USD116,000,000USD-3,176,000,000USD——
    Exchange Rate Changes——————-18,000,000USD-8,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    Patients Impacted Annually, Minimum Disclosed

    Period endPeriodValueUnitSource
    2026-06-30annual_run_rate150,000,000patients per year (minimum disclosed)Disclosure

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyInternational1,630,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States4,959,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational1,544,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyUnited States4,476,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30GeographyInternational1,486,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30GeographyUnited States4,571,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30GeographyInternational1,468,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30GeographyUnited States4,554,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30GeographyInternational1,385,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30GeographyUnited States4,109,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30SegmentMed Surg And Neurotechnology3,224,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30SegmentOrthopaedics And Spine2,270,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30GeographyInternational1,375,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30GeographyUnited States4,047,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30SegmentMed Surg And Neurotechnology3,117,000,000USD0000310764-24-000098
    Q2 2024Quarterly · 2024-06-30SegmentOrthopaedics And Spine2,305,000,000USD0000310764-24-000098
    Q1 2024Quarterly · 2024-03-31GeographyInternational1,329,000,000USDDisclosure
    Q1 2024Quarterly · 2024-03-31GeographyUnited States3,914,000,000USDDisclosure
    Q1 2024Quarterly · 2024-03-31SegmentMed Surg And Neurotechnology2,999,000,000USD0000310764-24-000064
    Q1 2024Quarterly · 2024-03-31SegmentOrthopaedics And Spine2,244,000,000USD0000310764-24-000064
    Q4 2023Quarterly · 2023-12-31SegmentMed Surg And Neurotechnology3,427,000,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31SegmentOrthopaedics And Spine2,388,000,000USDLegacy provider
    FY 2023Yearly · 2023-12-31SegmentMed Surg And Neurotechnology11,836,000,000USD0000310764-24-000024
    FY 2023Yearly · 2023-12-31SegmentOrthopaedics And Spine8,662,000,000USD0000310764-24-000024
    Q3 2023Quarterly · 2023-09-30GeographyInternational1,231,000,000USDDisclosure
    Q3 2023Quarterly · 2023-09-30GeographyUnited States3,678,000,000USDDisclosure
    Q3 2023Quarterly · 2023-09-30SegmentMed Surg And Neurotechnology2,859,000,000USDDisclosure
    Q3 2023Quarterly · 2023-09-30SegmentOrthopaedics And Spine2,050,000,000USDDisclosure
    Q2 2023Quarterly · 2023-06-30SegmentMed Surg And Neurotechnology2,860,000,000USD0000310764-24-000098
    Q2 2023Quarterly · 2023-06-30SegmentOrthopaedics And Spine2,136,000,000USD0000310764-24-000098
    Q1 2023Quarterly · 2023-03-31SegmentMed Surg And Neurotechnology2,690,000,000USD0000310764-24-000064
    Q1 2023Quarterly · 2023-03-31SegmentOrthopaedics And Spine2,088,000,000USD0000310764-24-000064
    Q4 2022Quarterly · 2022-12-31SegmentMed Surg And Neurotechnology3,051,000,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31SegmentOrthopaedics And Spine2,151,000,000USDLegacy provider
    FY 2022Yearly · 2022-12-31SegmentMed Surg And Neurotechnology10,611,000,000USD0000310764-24-000024
    FY 2022Yearly · 2022-12-31SegmentOrthopaedics And Spine7,838,000,000USD0000310764-24-000024
    FY 2021Yearly · 2021-12-31SegmentMed Surg And Neurotechnology9,538,000,000USD0000310764-24-000024
    FY 2021Yearly · 2021-12-31SegmentOrthopaedics And Spine7,570,000,000USD0000310764-24-000024
    FY 2020Yearly · 2020-12-31SegmentMed Surg And Neurotechnology8,345,000,000USD0000310764-23-000017
    FY 2020Yearly · 2020-12-31SegmentOrthopaedics And Spine6,006,000,000USD0000310764-23-000017
    FY 2019Yearly · 2019-12-31SegmentMed Surg And Neurotechnology8,475,000,000USD0000310764-22-000028
    FY 2019Yearly · 2019-12-31SegmentOrthopaedics And Spine6,409,000,000USD0000310764-22-000028
    FY 2017Yearly · 2017-12-31SegmentMedsurg5,557,000,000USD0000310764-18-000031
    FY 2017Yearly · 2017-12-31SegmentNeurotechnology And Spine2,174,000,000USD0000310764-18-000031
    FY 2017Yearly · 2017-12-31SegmentReconstructive4,713,000,000USD0000310764-18-000031
    FY 2017Yearly · 2017-12-31GeographyAsia Pacific1,413,000,000USD0000310764-18-000031
    FY 2017Yearly · 2017-12-31GeographyEMEA1,567,000,000USD0000310764-18-000031
    FY 2017Yearly · 2017-12-31GeographyOther Foreign Countries405,000,000USD0000310764-18-000031
    FY 2017Yearly · 2017-12-31GeographyUnited States9,059,000,000USD0000310764-18-000031
    FY 2016Yearly · 2016-12-31SegmentMedsurg4,894,000,000USD0000310764-18-000031
    FY 2016Yearly · 2016-12-31SegmentNeurotechnology And Spine2,009,000,000USD0000310764-18-000031
    FY 2016Yearly · 2016-12-31SegmentReconstructive4,422,000,000USD0000310764-18-000031
    FY 2016Yearly · 2016-12-31GeographyAsia Pacific1,325,000,000USD0000310764-18-000031
    FY 2016Yearly · 2016-12-31GeographyEMEA1,437,000,000USD0000310764-18-000031
    FY 2016Yearly · 2016-12-31GeographyOther Foreign Countries333,000,000USD0000310764-18-000031
    FY 2016Yearly · 2016-12-31GeographyUnited States8,230,000,000USD0000310764-18-000031
    FY 2015Yearly · 2015-12-31SegmentMedsurg3,895,000,000USD0000310764-18-000031
    FY 2015Yearly · 2015-12-31SegmentNeurotechnology And Spine1,828,000,000USD0000310764-18-000031
    FY 2015Yearly · 2015-12-31SegmentReconstructive4,223,000,000USD0000310764-18-000031
    FY 2015Yearly · 2015-12-31GeographyAsia Pacific1,251,000,000USD0000310764-18-000031
    FY 2015Yearly · 2015-12-31GeographyEMEA1,267,000,000USD0000310764-18-000031
    FY 2015Yearly · 2015-12-31GeographyOther Foreign Countries312,000,000USD0000310764-18-000031
    FY 2015Yearly · 2015-12-31GeographyUnited States7,116,000,000USD0000310764-18-000031
    FY 2014Yearly · 2014-12-31GeographyAsia Pacific1,368,000,000USD0000310764-17-000034
    FY 2014Yearly · 2014-12-31GeographyEMEA1,371,000,000USD0000310764-17-000034
    FY 2014Yearly · 2014-12-31GeographyOther Foreign Countries378,000,000USD0000310764-17-000034
    FY 2014Yearly · 2014-12-31GeographyUnited States6,558,000,000USD0000310764-17-000034
    FY 2013Yearly · 2013-12-31GeographyAsia Pacific1,319,000,000USD0000310764-16-000226
    FY 2013Yearly · 2013-12-31GeographyEMEA1,316,000,000USD0000310764-16-000226
    FY 2013Yearly · 2013-12-31GeographyOther Foreign Countries402,000,000USD0000310764-16-000226
    FY 2013Yearly · 2013-12-31GeographyUnited States5,984,000,000USD0000310764-16-000226
    FY 2012Yearly · 2012-12-31GeographyAsia Pacific1,336,000,000USD0000310764-15-000022
    FY 2012Yearly · 2012-12-31GeographyEMEA1,266,000,000USD0000310764-15-000022
    FY 2012Yearly · 2012-12-31GeographyOther Foreign Countries397,000,000USD0000310764-15-000022
    FY 2012Yearly · 2012-12-31GeographyUnited States5,658,000,000USD0000310764-15-000022

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.